tradingkey.logo

Cooper Companies Inc

COO
查看詳細走勢圖
82.750USD
+0.290+0.35%
收盤 12/19, 16:00美東報價延遲15分鐘
16.21B總市值
43.95本益比TTM

Cooper Companies Inc

82.750
+0.290+0.35%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.35%

5天

+0.82%

1月

+16.37%

6月

+19.12%

今年開始到現在

-9.99%

1年

-11.44%

查看詳細走勢圖

TradingKey Cooper Companies Inc股票評分

單位: USD 更新時間: 2025-12-19

操作建議

Cooper Companies Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名39/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價90.80。中期看,股價處於上升通道。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Cooper Companies Inc評分

相關信息

行業排名
39 / 208
全市場排名
117 / 4582
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 20 分析師
買入
評級
90.797
目標均價
+16.35%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Cooper Companies Inc亮點

亮點風險
The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入4.09B美元
估值合理
公司最新PE估值43.95,處於3年歷史合理位
機構減倉
最新機構持股208.96M股,環比減少0.00%
雷·達裡奧持倉
明星投資者雷·達裡奧持倉,最新持倉6.86K股

Cooper Companies Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Cooper Companies Inc簡介

The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
公司代碼COO
公司Cooper Companies Inc
CEOWhite (Albert G)
網址https://www.coopercos.com/

常見問題

Cooper Companies Inc(COO)的當前股價是多少?

Cooper Companies Inc(COO)的當前股價是 82.750。

Cooper Companies Inc 的股票代碼是什麼?

Cooper Companies Inc的股票代碼是COO。

Cooper Companies Inc股票的52週最高點是多少?

Cooper Companies Inc股票的52週最高點是100.240。

Cooper Companies Inc股票的52週最低點是多少?

Cooper Companies Inc股票的52週最低點是61.775。

Cooper Companies Inc的市值是多少?

Cooper Companies Inc的市值是16.21B。

Cooper Companies Inc的淨利潤是多少?

Cooper Companies Inc的淨利潤為374.90M。

現在Cooper Companies Inc(COO)的股票是買入、持有還是賣出?

根據分析師評級,Cooper Companies Inc(COO)的總體評級為買入,目標價格為90.797。

Cooper Companies Inc(COO)股票的每股收益(EPS TTM)是多少

Cooper Companies Inc(COO)股票的每股收益(EPS TTM)是1.883。
KeyAI